Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview
- PMID: 32429547
- PMCID: PMC7281533
- DOI: 10.3390/cancers12051265
Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview
Abstract
Chemoprevention of lung cancer is thought to significantly reduce the risk of acquiring these conditions in the subpopulation of patients with underlying health issues, such as chronic obstructive pulmonary disorder and smoking-associated lung problems. Many strategies have been tested in the previous decades, with very few translating to successful clinical trials in specific subpopulations of patients. In this review, we analyze these strategies, as well as new approaches that have emerged throughout the last few years, including synthetic lethality concept and microbiome-induced regulation of lung carcinogenesis. Overall, the continuous effort in the area of lung chemoprevention is required to develop practical therapeutical approaches. Given the inconsistency of results obtained in clinical trials targeting lung cancer chemoprevention in various subgroups of patients that differ in the underlying health condition, race, and gender, we believe that individualized approaches will have more promise than generalized treatments.
Keywords: cigarette smoke; inflammation; nicotine; oxidative stress; repurposing; tumorigenesis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Chemoprevention of lung cancer: current status and future prospects.Lung Cancer. 2003 Dec;42 Suppl 1:S71-9. doi: 10.1016/s0169-5002(03)00307-6. Lung Cancer. 2003. PMID: 14611918 Review.
-
Chemoprevention of lung cancer.Lung Cancer. 2001 Dec;34 Suppl 3:S91-4. doi: 10.1016/s0169-5002(01)00380-4. Lung Cancer. 2001. PMID: 11741000 Review.
-
Chemoprevention strategies for non-small cell lung cancer.Curr Opin Oncol. 2002 Mar;14(2):185-90. doi: 10.1097/00001622-200203000-00008. Curr Opin Oncol. 2002. PMID: 11880709 Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis.Mutat Res. 2003 Feb-Mar;523-524:237-52. doi: 10.1016/s0027-5107(02)00340-8. Mutat Res. 2003. PMID: 12628522 Review.
Cited by
-
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.Thorac Cancer. 2021 Mar;12(6):880-889. doi: 10.1111/1759-7714.13852. Epub 2021 Feb 1. Thorac Cancer. 2021. PMID: 33527756 Free PMC article.
-
First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer.Lung Cancer. 2021 Apr;154:99-104. doi: 10.1016/j.lungcan.2021.02.015. Epub 2021 Feb 17. Lung Cancer. 2021. PMID: 33636454 Free PMC article.
-
The β-Blocker Carvedilol Prevents Benzo(a)pyrene-Induced Lung Toxicity, Inflammation and Carcinogenesis.Cancers (Basel). 2023 Jan 18;15(3):583. doi: 10.3390/cancers15030583. Cancers (Basel). 2023. PMID: 36765542 Free PMC article.
-
Popularity of Traditional Chinese Medicine Use Among Breast Cancer Patients in North China: A Cross-Sectional Study.Breast Cancer (Dove Med Press). 2023 Aug 10;15:577-589. doi: 10.2147/BCTT.S416998. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 37583907 Free PMC article.
-
Mechanism and clinical application of thymosin in the treatment of lung cancer.Front Immunol. 2023 Aug 28;14:1237978. doi: 10.3389/fimmu.2023.1237978. eCollection 2023. Front Immunol. 2023. PMID: 37701432 Free PMC article. Review.
References
-
- The Health Consequences of Smoking: A Report of the Surgeon General. US Department of Health and Human Services; Atlanta, GA, USA: 2004.
-
- Links C. Surgeon General’s Advisory on E-Cigarette Use among Youth. Arizona Free Press; Rockville, MD, USA: 2018.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources